Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema.

Main|Search|PHGKB






Last Posted: Jul 26, 2018

---

• Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema.
  Aygören-Pürsün Emel et al. The New England journal of medicine 2018 Jul (4) 352-362
• Analysis of First-Year Twitter Metrics of a Rare Disease Community for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) on Social Media: #BPDCN.
  Pemmaraju Naveen et al. Current hematologic malignancy reports 2017 Dec 12(6) 592-597
• Expanded Carrier Screening: A Rational Approach to Screening for Rare Diseases.
  Norton Mary E et al. Obstetrics and gynecology 2017 130(2) 260-261
• Machine Learning
  NIH Catalyst, July 2018
• Protein affected by rare Parkinson’s mutation may lurk behind many cases of the disease
  NIH News, July 25, 2018
• FDA Issues Set of Gene Therapy Draft Guidances
  Global Genes, July 11, 2018
• Hereditary Hemochromatosis
  CDC, July 2018
• When you have a serious hereditary disease, who has a right to know
  S Raviv, Mosaic, Wellcome, July 11, 2018
• Diagnosis and management of Cornelia de Lange syndrome: first international consensus statement
  AD Kline et al, Nat Rev Genetics, July 11, 2018
• How Routine Genomic Medicine 'Will Change People's Lives'
  P Russell, Medscape, July 11, 2018

more